Encompass Health Operating Income Over Time
| EHC Stock | USD 107.20 1.07 1.01% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Encompass Health Performance and Encompass Health Correlation. Encompass | Build AI portfolio with Encompass Stock |
Will Health Care Providers & Services sector continue expanding? Could Encompass diversify its offerings? Factors like these will boost the valuation of Encompass Health. Projected growth potential of Encompass fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Encompass Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.208 | Dividend Share 0.72 | Earnings Share 5.55 | Revenue Per Share | Quarterly Revenue Growth 0.099 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Encompass Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Encompass Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Encompass Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Operating Income Analysis
Compare Encompass Health Corp and related stocks such as Solventum Corp, Ensign Group, and Universal Health Services Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLV | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.4 B | 1.9 B | 1.7 B | 1.7 B | 1 B | 932.4 M | 1.2 B |
| ENSG | 5.9 M | 90.7 M | 78.3 M | 57.9 M | 72.9 M | 93.1 M | 91.8 M | 43.2 M | 84.9 M | 129.2 M | 223.2 M | 260.5 M | 296.8 M | 255.4 M | 358.3 M | 433.8 M | 455.5 M |
| UHS | 67.9 M | 897.1 M | 942.6 M | 1 B | 1.1 B | 1.3 B | 1.3 B | 1.3 B | 1.2 B | 1.2 B | 1.4 B | 1.4 B | 1 B | 1.2 B | 1.7 B | 2 B | 2.1 B |
| ELAN | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 283.2 M | 142.4 M | 313.8 M | 370 M | (76.8 M) | 304 M | 384 M | 326 M | 251 M | 252 M | 255.5 M |
| RDY | 17.4 M | 18.3 B | 21.1 B | 26 B | 26.3 B | 29.6 B | 13.5 B | 11.9 B | 20.9 B | 16 B | 431.4 M | 29.5 B | 57.1 B | 67.7 B | 71.8 B | 82.6 B | 86.8 B |
| DVA | 17.2 M | 1.2 B | 1.3 B | 1.6 B | 1.8 B | 1.1 B | 2 B | 1.8 B | 1.5 B | 1.6 B | 1.7 B | 1.8 B | 1.3 B | 1.6 B | 2.1 B | 2 B | 1.1 B |
| ICLR | 42.1 M | 39.3 M | 72.4 M | 121.2 M | 202.3 M | 281.5 M | 311.7 M | 338.3 M | 373.4 M | 433.4 M | 391.5 M | 378.5 M | 795.2 M | 956.2 M | 1.1 B | 1.3 B | 1.3 B |
| FMS | 3 B | 1.6 B | 1.7 B | 1.6 B | 1.9 B | 2.1 B | 2.5 B | 2.4 B | 3 B | 2.3 B | 2.3 B | 1.9 B | 1.5 B | 1.4 B | 1.4 B | 1.8 B | 1.6 B |
| CHE | 43.4 M | 153.7 M | 156.4 M | 133.4 M | 168.4 M | 184.5 M | 178.7 M | 113 M | 243.6 M | 257.4 M | 389.7 M | 343 M | 343.5 M | 340.6 M | 366.5 M | 338.2 M | 355.2 M |
| ALGN | (14.7 M) | 90.4 M | 85.6 M | 94.2 M | 193.6 M | 188.6 M | 248.9 M | 353.6 M | 466.6 M | 542.5 M | 387.2 M | 976.4 M | 642.6 M | 643.3 M | 607.6 M | 616.2 M | 647 M |
Encompass Health Corp and related stocks such as Solventum Corp, Ensign Group, and Universal Health Services Operating Income description
Operating Income is the amount of profit realized from Encompass Health Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Encompass Health Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Encompass Health Corp | EHC |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 9001 Liberty Parkway, |
| Exchange | New York Stock Exchange |
USD 107.2
Check out Encompass Health Performance and Encompass Health Correlation. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Encompass Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.